Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
26.56
-0.37 (-1.37%)
At close: May 30, 2025, 4:00 PM
26.52
-0.04 (-0.15%)
After-hours: May 30, 2025, 7:58 PM EDT
Moderna Stock Forecast
Stock Price Forecast
According to 16 professional analysts, the 12-month price target for Moderna stock ranges from a low of $26 to a high of $80. The average analyst price target of $48.13 forecasts a 81.21% increase in the stock price over the next year.
Price Target: $48.13 (+81.21%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Moderna stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 2 | 2 | 2 | 2 | 2 |
Buy | 2 | 2 | 1 | 1 | 1 | 1 |
Hold | 11 | 13 | 14 | 14 | 14 | 13 |
Sell | 3 | 3 | 3 | 3 | 3 | 3 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 19 | 20 | 20 | 20 | 20 | 19 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
JP Morgan | JP Morgan | Sell Maintains $33 → $26 | Sell | Maintains | $33 → $26 | -2.11% | May 22, 2025 |
UBS | UBS | Strong Buy Maintains $78 → $70 | Strong Buy | Maintains | $78 → $70 | +163.55% | May 2, 2025 |
Barclays | Barclays | Hold Maintains $45 → $40 | Hold | Maintains | $45 → $40 | +50.60% | May 2, 2025 |
RBC Capital | RBC Capital | Hold Maintains $32 → $28 | Hold | Maintains | $32 → $28 | +5.42% | May 2, 2025 |
Evercore ISI Group | Evercore ISI Group | Hold Maintains $50 → $32 | Hold | Maintains | $50 → $32 | +20.48% | May 2, 2025 |
Financial Forecast
Revenue This Year
2.14B
from 3.24B
Decreased by -33.93%
Revenue Next Year
2.33B
from 2.14B
Increased by 8.98%
EPS This Year
-10.43
from -9.28
EPS Next Year
-8.04
from -10.43
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 2.6B | 3.8B | 4.3B | ||
Avg | 2.1B | 2.3B | 2.9B | ||
Low | 1.7B | 1.3B | 1.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -20.1% | 79.6% | 86.4% | ||
Avg | -33.9% | 9.0% | 23.5% | ||
Low | -48.1% | -37.8% | -25.5% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | -9.98 | -5.87 | -2.23 | ||
Avg | -10.43 | -8.04 | -5.16 | ||
Low | -11.17 | -9.58 | -7.23 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.